Social anxiety disorder: appendices

  • Appendices 1-9:

    - Appendix 1: Scope for the development of the clinical guideline

    - Appendix 2: Declarations of interests by Guideline Development Group members

    - Appendix 3: Special advisors to the Guideline Development Group

    - Appendix 4: Stakeholders and experts who submitted comments in response to the consultation draft of the guideline

    - Appendix 5: Researchers contacted to request further data

    - Appendix 6: Search strategies for the identification of clinical studies

    - Appendix 7: Search strategies for the identification of health economics evidence

    - Appendix 8: Methodology checklist for economic studies

    - Appendix 9: Research Recommendations
  • Appendix 10: Completed methodology checklists - Case ID and assessment
  • Appendix 11: Network Meta-analysis - Network diagrams and results
  • Appendix 12: Interventions for adults (network analysis) - study characteristics
  • Appendix 13: Interventions for adults (subgroups) - study characteristics
  • Appendix 14: Interventions for adults (subgroups) - forest plots
  • Appendix 15: Interventions for specific subgroups (adults) - GRADE evidence profiles
  • Appendix 16: Interventions for children and young people - study characteristics
  • Appendix 17: Interventions for children and young people - forest plots
  • Appendix 18: Relapse prevention (adults) - study characteristics
  • Appendix 19: Interventions for children and young people - GRADE evidence profiles
  • Appendix 20: Risk of Bias summaries for adults and CYP
  • Appendix 21: Economic evidence - completed methodology checklists
  • Appendix 22: Economic evidence - evidence tables of published studies
  • Appendix 23: Health Economics detailed results
  • Appendix 24: Health Economics profile
  • Appendix 25: Excluded studies table
  • Appendix 26: Relapse prevention (adults) - forest plots

This page was last updated: 10 December 2012